Axsome Therapeutics (AXSM) Q3 2024 Earnings Call Transcript

By Yahoo! Finance | Nov 12, 2024 at 03:27 PM EST

Axsome Therapeutics reported strong financial results and progress in advancing innovative medicines. The company plans to expand its sales force for Auvelity and is optimistic about potential growth in various therapeutic areas. Key milestones include upcoming data readouts for Alzheimer's disease agitation and migraine.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.